Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current DMPI market cap is 74.11M. The company's latest EPS is USD -0.1537 and P/E is -49.06.
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -3.35M | -2.96M | -1.02M | -2.09M | -2.39M |
| Net Income | -3.34M | -3.14M | -1.03M | -2.01M | -2.33M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -9.2M | -38.17M | -22.68M | -14.8M | -8.45M |
| Net Income | -9.14M | -41.5M | -22.66M | -15.02M | -8.5M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 3.98M | 1.48M | 1.89M | 7.45M | 6.2M |
| Total Liabilities | 3.25M | 3.5M | 2.05M | 1.52M | 2.45M |
| Total Equity | 731k | -2.03M | -164k | 5.92M | 3.76M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.94M | 13.54M | 15.95M | 3.98M | 6.2M |
| Total Liabilities | 2.68M | 2.96M | 4.15M | 3.25M | 2.45M |
| Total Equity | 263k | 10.58M | 11.8M | 731k | 3.76M |
| Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.87M | -1.32M | -3.43M | -5.73M | -7.18M |
| Investing | -232k | N/A | -20k | -20k | -20k |
| Financing | 1.85M | -2k | 2.58M | 10.57M | 10.57M |
| Year End 30 June 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -7.93M | -18.86M | -20.39M | -11.87M | -7.18M |
| Investing | N/A | 964k | N/A | -232k | -20k |
| Financing | 6.6M | 26.04M | 21.64M | 1.85M | 10.57M |
| Market Cap | 74.11M |
| Price to Earnings Ratio | -49.06 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 84.91 |
| Price to Book Ratio | 110.99 |
| Dividend Yield | - |
| Shares Outstanding | 55.31M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.02 (1.49%) |
| Company Name | DelMar Pharmaceuticals Inc |
| Address |
50 west liberty street reno, nevada 89501 |
| Website | https://www.kintara.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
